Skip to Main Content

Paper Details

Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer.
Mol Oncol
36
2018
Author NameAffiliation
Rita BarrosInstitute of Molecular Pathology and Immunology, University of Porto (IPATIMUP)
Rita BarrosUniversity of Porto
Rita BarrosInstituto de Investigacao e InovacaoemSaude (i3S)
Olli KallioniemiInstitute for Molecular Medicine Finland (FIMM), University of Helsinki
Olli Kallioniemi
Olli KallioniemiKarolinska Institutet
  • 1 - 6

Datasets

Release 1.2